Related Programs

Cancer 101 Cancer Care Scores Higher Marks What to Expect When Getting a CAT Scan Cancer and Cancer Treatment: Can it Affect Sleep?

Cervical Cancer

Molecular Targeted Therapy: A New Way of Treating Cancer

Summary & Participants

Molecular targeted therapies may become a revolutionary change in the treatment of cancer. Listen as experts describe how these drugs are being used today and what may lie ahead.

Medically Reviewed On: July 14, 2008

Webcast Transcript

ANNOUNCER: Researchers have learned a great deal in recent years about how some cancers develop. That knowledge is beginning to pay off, with the development of new medicines that narrowly target those processes.

PAUL BUNN, MD: So in the last 30 years since the war on cancer started with the National Cancer Act, we've made a lot of basic science advances that define how a cancer cell is different from a normal cell. The proteins and the genes that make it different are the targets, so we have new therapies now that are designed to inhibit these genes and proteins associated with cancer. So that's what people mean by molecularly targeted therapy: therapy that's targeted towards genes and proteins that are different on cancer cells compared to normal human cells.

ANNOUNCER: What's different in the cancer cell are abnormalities in the biochemical circuits that control cell growth and death. The "switches" in these circuits can be in the nucleus of the cell: in its body or on the surface.

ROMAN PEREZ-SOLER, MD: Signaling pathways are basically switches on the surface of the cell that are turned on and off. If you turn them on, the cell grows and divides. If you are a tumor and you turn it on, what happens is then that the tumor grows.

So you attack the signaling pathways by going to the surface of the cell and blocking the switch, or you can just go inside all that circuit and block it somewhere inside.

ANNOUNCER: Another approach in "targeted" therapy is called angiogenesis inhibition, which deprives the cancer of its blood supply.

PAUL BUNN, MD: When you block blood vessel formation the tumor will shrink and die because it doesn't get oxygen.

ANNOUNCER: The various types of molecular targeted therapy can be very effective. Often with few side effects.

ROMAN PEREZ-SOLER, MD: The excitement is the higher degree of specificity, which basically means therapeutic effect with fewer side effects, and probably more therapeutic effect. Because as we really attack the pathway that is the secret of that cell, we basically very specifically harm that cell without damaging the rest of the body.

ANNOUNCER: Chemotherapy, in contrast, affects many types of normal cells, causing side effects such as hair loss, nausea and vomiting. And what's often most serious, low blood counts. Targeted drugs have side effects too. But they are usually quite mild.

PAUL BUNN, MD: Many of the targeted therapies may cause diarrhea. Some of them cause skin rash. Some of them cause fatigue. But generally these side effects are (a) mild, and (b) are reversible by either discontinuing the drug for a short period of time or lowering the dose.

ANNOUNCER: Many targeted therapies are being studied only in the lab, or in clinical trials. But quite a few of the drugs are already being used in clinical practice.

Page 1 of 2 Next Page >>